Katharina Dalton
Katharina Dalton (11 November 1916 – 17 September 2004) was a British physician and researcher who pioneered the study of premenstrual syndrome (PMS) and is credited with coining the term. Her work significantly advanced the understanding of PMS and its treatment, making her a key figure in the fields of gynecology and endocrinology.
Early Life and Education[edit | edit source]
Katharina Dalton was born in London, England. She pursued her medical education at the University of London, where she specialized in gynecology. Dalton's interest in the hormonal aspects of women's health led her to focus on the physiological and psychological changes occurring in the menstrual cycle.
Career and Research[edit | edit source]
Dalton's career was marked by her groundbreaking research on premenstrual syndrome, a term she first used in a 1953 paper. Before her work, the symptoms associated with PMS were largely unrecognized by the medical community. Dalton conducted extensive studies on the subject, advocating for the recognition of PMS as a serious and treatable condition.
She proposed that PMS was caused by a deficiency in progesterone during the luteal phase of the menstrual cycle and suggested treating the condition with progesterone supplements. Dalton's approach to treatment provided relief for many women suffering from PMS, although her theories and methods were sometimes controversial and sparked debate within the medical community.
In addition to her research on PMS, Dalton wrote several books on the subject, aiming to increase public awareness and understanding of the condition. Her publications, including "The Premenstrual Syndrome" and "Once a Month," played a crucial role in bringing PMS to the forefront of women's health issues.
Legacy[edit | edit source]
Katharina Dalton's contributions to the field of gynecology and her pioneering work on premenstrual syndrome have left a lasting impact on the way PMS is perceived and treated. She is remembered as a dedicated physician who worked tirelessly to improve the lives of women suffering from PMS. Dalton's research opened the door for further studies on the condition, leading to a better understanding of its causes and treatments.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD